Equity Overview
Price & Market Data
Price: $4.48
Daily Change: -$0.04 / 0.89%
Daily Range: $4.41 - $4.54
Market Cap: $39,516,888
Daily Volume: 50,469
Performance Metrics
1 Week: -1.54%
1 Month: 11.17%
3 Months: 118.5%
6 Months: 86.67%
1 Year: 74.77%
YTD: 140.9%
Company Details
Employees: 26
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with a range of anti-cancer regimens. The company was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.